✦ LIBER ✦

The Cost-Effectiveness of Oral Direct Factor Xa Inhibitors Compared with Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement Surgery

✍ Scribed by Mahmoudi, Mandana; Sobieraj, Diana M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The direct thrombin inhibitor melagatran

✍ B. I. Eriksson; G. Agnelli; A. T. Cohen; O. E. Dahl; M. R. Lassen; P. Mouret; N. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Dose-escalation study of rivaroxaban (BA

✍ Bengt I. Eriksson; Lars C. Borris; Ola E. Dahl; Sylvia Haas; Menno V. Huisman; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 302 KB

BAY 59-7939: an oral, direct Factor Xa i

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

A new oral direct thrombin inhibitor, da

✍ B. I. ERIKSSON; O. E. DAHL; H. R. BÜLLER; R. HETTIARACHCHI; N. ROSENCHER; M-L. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

AVE5026, a new hemisynthetic ultra-low-m

✍ M. R. LASSEN; O. E. DAHL; P. MISMETTI; D. DESTRÉE; A. G. G. TURPIE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB